.png){kind=icon}
返回
Machine learning-based cytokine microarray digital immunoassay analysis
.png){kind=icon}
OA
AI
DOI：10.1016/j.bios.2021.113088.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Serial measurement of a large panel of protein biomarkers near the bedside could provide a promising pathway to transform the critical care of acutely ill patients. However, attaining the combination of high sensitivity and multiplexity with a short assay turnaround poses a formidable technological challenge. Here, the authors develop a rapid, accurate, and highly multiplexed microfluidic digital immunoassay by incorporating machine learningbased autonomous image analysis. The assay has achieved 12-plexed biomarker detection in sample volume <15 ILL at concentrations < 5 pg/mL while only requiring a 5-min assay incubation, allowing for all processes from sampling to result to be completed within 40 min. The assay procedure applies both a spatial-spectral microfluidic encoding scheme and an image data analysis algorithm based on machine learning with a convolutional neural network (CNN) for pre-equilibrated single-molecule protein digital counting. This unique approach remarkably reduces errors facing the high-capacity multiplexing of digital immunoassay at low protein concentrations. Longitudinal data obtained for a panel of 12 serum cytokines in human patients receiving chimeric antigen receptor-T (CAR-T) cell therapy reveals the powerful biomarker profiling capability. The assay could also be deployed for near-real-time immune status monitoring of critically ill COVID-19 patients developing cytokine storm syndrome.
Keyword:
Microfluidic digital immunoassay
Multiplex biomarker detection
Machine learning
Cytokine release syndrome
CAR-T therapy
期刊
IF:
10.5
论文数:
1.8W
被引数:
7.7W
机构
引用论文
分享收藏Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China武汉地区2019例新型冠状病毒感染患者临床特征分析.png)
LANCET
OAAI
LANCETIF88.5
OAAI分享收藏Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia急性淋巴细胞白血病嵌合抗原受体T细胞治疗后细胞因子释放综合征预测生物标志物的鉴定CANCER DISCOVERYOAAI
CANCER DISCOVERYIF33.3
OAAI分享收藏Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory TherapyASAIO JOURNALOAAI
ASAIO JOURNALIF2.3
OAAI分享收藏Biotunable Nanoplasmonic Filter on Few-Layer MoS2 for Rapid and Highly Sensitive Cytokine Optoelectronic lmmunosensingACS NANO
ACS NANOIF16
PREAI
分享收藏
查看更多内容